Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
904
-
Total 13F shares, excl. options
-
327M
-
Shares change
-
+4.85M
-
Total reported value, excl. options
-
$14.4B
-
Value change
-
+$217M
-
Put/Call ratio
-
0.21
-
Number of buys
-
441
-
Number of sells
-
-291
-
Price
-
$44.10
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q4 2021
985 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q4 2021.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 904 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 327M shares
.
Largest 10 shareholders include Dodge & Cox (88.5M shares), Capital International Investors (19.1M shares), Fisher Asset Management, LLC (18.2M shares), FMR LLC (17.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (15.1M shares), Black Creek Investment Management Inc. (10.4M shares), RENAISSANCE TECHNOLOGIES LLC (10.2M shares), STATE STREET CORP (9.01M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (8.62M shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (7.26M shares).
This table shows the top 904 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.